Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES PHARMA SCIENCE DIVIS LABORATORIES STRIDES PHARMA SCIENCE/
DIVIS LABORATORIES
 
P/E (TTM) x -1,455.3 66.0 - View Chart
P/BV x 3.3 7.1 45.9% View Chart
Dividend Yield % 0.2 0.9 22.0%  

Financials

 STRIDES PHARMA SCIENCE   DIVIS LABORATORIES
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-23
DIVIS LABORATORIES
Mar-23
STRIDES PHARMA SCIENCE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3924,641 8.5%   
Low Rs2632,730 9.7%   
Sales per share (Unadj.) Rs408.5292.6 139.6%  
Earnings per share (Unadj.) Rs-25.668.7 -37.2%  
Cash flow per share (Unadj.) Rs1.481.6 1.7%  
Dividends per share (Unadj.) Rs1.5030.00 5.0%  
Avg Dividend yield %0.50.8 56.2%  
Book value per share (Unadj.) Rs242.8480.9 50.5%  
Shares outstanding (eoy) m90.30265.47 34.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.812.6 6.4%   
Avg P/E ratio x-12.853.7 -23.9%  
P/CF ratio (eoy) x239.645.2 530.7%  
Price / Book Value ratio x1.47.7 17.6%  
Dividend payout %-5.943.7 -13.4%   
Avg Mkt Cap Rs m29,603978,378 3.0%   
No. of employees `000NANA-   
Total wages/salary Rs m7,3209,750 75.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m36,88477,675 47.5%  
Other income Rs m1,3523,447 39.2%   
Total revenues Rs m38,23681,122 47.1%   
Gross profit Rs m83023,691 3.5%  
Depreciation Rs m2,4333,432 70.9%   
Interest Rs m2,61120 13,323.6%   
Profit before tax Rs m-2,86223,686 -12.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-5535,453 -10.1%   
Profit after tax Rs m-2,30918,234 -12.7%  
Gross profit margin %2.230.5 7.4%  
Effective tax rate %19.323.0 83.9%   
Net profit margin %-6.323.5 -26.7%  
BALANCE SHEET DATA
Current assets Rs m31,35397,437 32.2%   
Current liabilities Rs m29,90215,331 195.0%   
Net working cap to sales %3.9105.7 3.7%  
Current ratio x1.06.4 16.5%  
Inventory Days Days718 849.0%  
Debtors Days Days129842 15.3%  
Net fixed assets Rs m31,30051,128 61.2%   
Share capital Rs m903531 170.1%   
"Free" reserves Rs m21,025127,140 16.5%   
Net worth Rs m21,928127,671 17.2%   
Long term debt Rs m11,3980-   
Total assets Rs m63,734148,565 42.9%  
Interest coverage x-0.11,209.5 -0.0%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.60.5 110.7%   
Return on assets %0.512.3 3.9%  
Return on equity %-10.514.3 -73.7%  
Return on capital %-0.818.6 -4.0%  
Exports to sales %46.785.7 54.5%   
Imports to sales %019.8 0.0%   
Exports (fob) Rs m17,21366,537 25.9%   
Imports (cif) Rs mNA15,378 0.0%   
Fx inflow Rs m18,11366,537 27.2%   
Fx outflow Rs m67215,715 4.3%   
Net fx Rs m17,44250,822 34.3%   
CASH FLOW
From Operations Rs m44424,597 1.8%  
From Investments Rs m3,025-27,076 -11.2%  
From Financial Activity Rs m-2,139-7,972 26.8%  
Net Cashflow Rs m1,328-10,451 -12.7%  

Share Holding

Indian Promoters % 27.4 51.9 52.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 38.9 36.7 105.8%  
FIIs % 19.5 14.9 131.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 48.1 151.0%  
Shareholders   91,182 354,482 25.7%  
Pledged promoter(s) holding % 69.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES PHARMA SCIENCE With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on STRIDES PHARMA SCIENCE vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

STRIDES PHARMA SCIENCE vs Divis Laboratories Share Price Performance

Period STRIDES PHARMA SCIENCE Divis Laboratories S&P BSE HEALTHCARE
1-Day 1.16% 2.14% 1.18%
1-Month 0.35% -2.15% -0.75%
1-Year 176.88% 22.51% 61.82%
3-Year CAGR -3.35% -1.38% 18.16%
5-Year CAGR 10.98% 15.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the STRIDES PHARMA SCIENCE share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of STRIDES PHARMA SCIENCE hold a 27.4% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of STRIDES PHARMA SCIENCE and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, STRIDES PHARMA SCIENCE paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of -5.9%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of STRIDES PHARMA SCIENCE, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.